Wichterman Troy Transactions with BIOLIFE SOLUTIONS INC
2026-10-08SEC Filing 4 (0001193125-26-418329)
On October 6, 2026, Troy Wichterman, Chief Financial Officer of BIOLIFE SOLUTIONS INC (BLFS), reported several transactions involving common stock. These include the acquisition of 76,204 shares and 62,300 shares under the 2023 Omnibus Performance Incentive Plan, with vesting occurring immediately prior to a merger. Additionally, 95,933 shares were disposed of to cover tax withholding obligations. A significant disposition of 256,000 shares occurred in connection with the merger, where each share was converted into $11.25 cash and 0.1442 shares of Repligen common stock. Following these transactions, Wichterman